A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
- PMID: 32552307
- DOI: 10.1080/09537104.2020.1775189
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
Keywords: Btk; COVID-19; platelets; thromboinflammation.
Comment in
-
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors.Platelets. 2020 Nov 16;31(8):989-992. doi: 10.1080/09537104.2020.1809647. Epub 2020 Sep 6. Platelets. 2020. PMID: 32892684 No abstract available.
Comment on
-
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.Crit Care Resusc. 2020 Apr 15;22(2):95-97. doi: 10.51893/2020.2.pov2. Online ahead of print. Crit Care Resusc. 2020. PMID: 32294809 Free PMC article.
-
Thromboinflammation and the hypercoagulability of COVID-19.J Thromb Haemost. 2020 Jul;18(7):1559-1561. doi: 10.1111/jth.14849. Epub 2020 May 26. J Thromb Haemost. 2020. PMID: 32302453 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources